Blue Water Vaccines, Inc.
BWV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -1,303.20% | -296.06% | -419.79% | -1,319.03% |
| EV / EBITDA | 0.05 | -4.62 | -0.63 | -0.25 |
| Quality | ||||
| ROIC | -58.42% | -12.75% | -91.21% | -178.65% |
| Gross Margin | 88.55% | 66.20% | 45.10% | 60.11% |
| Cash Conversion Ratio | 0.36 | 0.59 | 0.23 | 0.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,243,695.17% | 1,265,546.95% | 1,379,492.75% | 1,361,458.91% |
| Free Cash Flow Growth | -125.33% | 29.47% | 68.17% | -446.90% |
| Safety | ||||
| Net Debt / EBITDA | 0.08 | -4.38 | -0.59 | -0.24 |
| Interest Coverage | -6.90 | -8.68 | -56.22 | 72.37 |
| Efficiency | ||||
| Inventory Turnover | 0.23 | 0.24 | 0.36 | 8.79 |
| Cash Conversion Cycle | -4,278.51 | -6,062.58 | -3,898.75 | -593.12 |